Tirzepatide

Tirzepatide is a dual GIP and GLP-1 receptor agonist investigated for its role in metabolic regulation, glucose control, appetite signaling, and body composition research. By engaging two incretin pathways, tirzepatide allows researchers to study how combined GIP and GLP-1 activity may influence insulin secretion, glucagon balance, food intake, lipid metabolism, and energy regulation. Its dual-receptor design makes it useful in research comparing single-pathway incretin activity with multi-pathway metabolic signaling. Tirzepatide is often examined in studies focused on obesity biology, type 2 diabetes mechanisms, adipose tissue behavior, and broader cardiometabolic health markers.